[1] LOOMBA R, SANYAL A J. The global NAFLD epidemic[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11):686-690. [2] MACHADO M V, CORTEZ-PINTO H. Non-alcoholic fatty liver disease:what the clinician needs to know[J]. World J Gastroenterol, 2014, 20(36):12956-12980. [3] WANG J, SUN B, HOU M, et al. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children[J]. Int J Obes (Lond), 2013, 37(7):999-1005. [4] MARMUGI A, DUCHEIX S, LASSERRE F, et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver[J]. Hepatology, 2012, 55(2):395-407. [5] BAILLIE-HAMILTON P F. Chemical toxins:a hypothesis to explain the global obesity epidemic[J]. J Altern Complement Med, 2002, 8(2):185-192. [6] VANDENBERG L N, HAUSER R, MARCUS M, et al. Human exposure to bisphenol A (BPA)[J]. Reproductive Toxicol, 2007, 24(2):139-177. [7] DING S B, FAN Y, ZHAO N N, et al. High-fat diet aggravates glucose homeostasis disorder caused by chronic exposure to bisphenol A[J]. J Endocrinol, 2014, 221(1):167-179. [8] HALDEN R U. Plastics and health risks[J]. Annu Rev Public Health, 2010, 31:179-194. [9] ARNOLD S M, CLARK K E, STAPLES C A, et al. Relevance of drinking water as a source of human exposure to bisphenol A[J]. J Expo Sci Environ Epidemiol, 2013, 23(2):137-144. [10] COLIN A, BACH C, ROSIN C, et al. Is drinking water a major route of human exposure to alkylphenol and bisphenol contaminants in France?[J]. Arch Environ Contam Toxicol, 2014, 66(1):86-99. [11] VANDENBERG L N, CHAHOUD I, HEINDEL J J, et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A[J]. Environ Health Perspect, 2010, 118(8):1055-1070. [12] WELSHONS W V, NAGEL S C, VOM SAAL F S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure[J]. Endocrinology, 2006, 147(Sup 6):S56-S69. [13] CALAFAT A M, YE X Y, WONG L Y, et al. Exposure of the US population to bisphenol A and 4-tertiary-octylphenol:2003-2004[J]. Environ Health Perspect, 2008, 116(1):39-44. [14] SAJIKI J, TAKAHASHI K, YONEKUBO J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography[J]. J Chromatogr B Biomed Sci Appl, 1999, 736(1/2):255-261. [15] VOM SAAL F S, WELSHONS W V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure[J]. Mol Cell Endocrinol, 2014, 398(1/2):101-113. [16] SAVASTANO S, TARANTINO G, D'ESPOSITO V, et al. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance:a cross-sectional study on adult male population[J]. J Transl Med, 2015, 13:169. [17] CAMARCA A, GIANFRANI C, ARIEMMA F, et al. Human peripheral blood mononuclear cell function and dendritic cell differentiation are affected by bisphenol-A exposure[J]. PLoS One, 2016, 11(8):e0161122. [18] HOWDESHELL K L, HOTCHKISS A K, THAYER K A, et al. Exposure to bisphenol A advances puberty[J]. Nature, 1999, 401(6755):763-764. [19] CABATON N J, WADIA P R, RUBIN B S, et al. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice[J]. Environ Health Perspect, 2011, 119(4):547-552. [20] SALIAN S, DOSHI T, VANAGE G. Neonatal exposure of male rats to Bisphenol A impairs fertility and expression of Sertoli cell junctional proteins in the testis[J]. Toxicology, 2009, 265(1/2):56-67. [21] MANIKKAM M, TRACEY R, GUERRERO-BOSAGNA C, et al. Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations[J]. PLoS One, 2013, 8(1):e55387. [22] MARTELLA A, SILVESTRI C, MARADONNA F, et al. Bisphenol A induces fatty liver by an endocannabinoid-mediated positive feedback loop[J]. Endocrinology, 2016, 157(5):1751-1763. [23] VOM SAAL F S. Bisphenol A and risk of metabolic disorders[J]. JAMA, 2008, 300(11):1353. [24] PRINS G S, BIRCH L, TANG W Y, et al. Developmental estrogen exposures predispose to prostate carcinogenesis with aging[J]. Reprod Toxicol, 2007, 23(3):374-382. [25] BHANDARI R, XIAO J, SHANKAR A. Urinary bisphenol A and obesity in US children[J]. Am J Epidemiol, 2013, 177(11):1263-1270. [26] DOLINOY D C, JIRTLE R L. Environmental epigenomics in human health and disease[J]. Environ Mol Mutagen, 2008, 49(1):4-8. [27] HUGO E R, BRANDEBOURG T D, WOO J G, et al. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes[J]. Environ Health Perspect, 2008, 116(12):1642-1647. [28] LANG I A, GALLOWAY T S, SCARLETT A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults[J]. JAMA, 2008, 300(11):1303-1310. [29] LI D, ZHOU Z, QING D, et al. Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction[J]. Hum Reprod, 2010, 25(2):519-527. [30] VALENTINO R, D'ESPOSITO V, ARIEMMA F, et al. Bisphenol A environmental exposure and the detrimental effects on human metabolic health:is it necessary to revise the risk assessment in vulnerable population?[J]. J Endocrinol Invest, 2016, 39(3):259-263. [31] MELZER D, RICE, LEWIS C, et al. Association of urinary bisphenol a concentration with heart disease:evidence from NHANES 2003/06[J]. PLoS One, 2010, 5(1):e8673. [32] BIEDERMANN S, TSCHUDIN P, GROB K. Transfer of bisphenol A from thermal printer paper to the skin[J]. Anal Bioanal Chem, 2010, 398(1):571-576. [33] BERNIER M R, VANDENBERG L N. Handling of thermal paper:Implications for dermal exposure to bisphenol A and its alternatives[J]. PLoS One, 2017, 12(6):e0178449. [34] MARMUGI A, LASSERRE F, BEUZELIN D, et al. Adverse effects of long-term exposure to bisphenol A during adulthood leading to hyperglycaemia and hypercholesterolemia in mice[J]. Toxicology, 2014, 325:133-143. [35] NEUSCHWANDER-TETRI B A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis:the central role of nontriglyceride fatty acid metabolites[J]. Hepatology, 2010, 52(2):774-788. [36] MATSUSUE K, AIBARA D, HAYAFUCHI R, et al. Hepatic PPARγ and LXRα independently regulate lipid accumulation in the livers of genetically obese mice[J]. FEBS Lett, 2014, 588(14):2277-2281. [37] TAM D N H, TRUONG D H, NGUYEN T T H, et al. Ginsenoside Rh1:a systematic review of its pharmacological properties[J]. Planta Med, 2018, 84(3):139-152. [38] GU W, KIM K A, KIM D H. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation[J]. Biol Pharm Bull, 2013, 36(1):102-107. |